# Emergent BioSolutions Inc.: Form 8-K, filed Aug 4, 2016

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2016-08-04
- Accepted by EDGAR: Aug 4, 2016, 17:25 ET
- Period: 2016-08-04
- Accession: 0001367644-16-000071
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764416000071/form8kdistribution08042016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764416000071/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764416000071/form8kdistribution08042016.htm

Filed Aug 4, 2016.
Source: SEC EDGAR, the filing index for accession 0001367644-16-000071. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
